Novartis earnings and sales fall short of expectations, but backs 2022 view
October 25, 2022 at 01:34 AM EDT
The Swiss pharma major reported third-quarter net profit of $1.58 billion, on sales which declined to $12.54 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|